Hologic
In Howard Marks's portfolio · Oaktree Capital Management
Ticker HOLX.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2016 | Reduce 34% | 41,635,000 | 0.9% |
| Q4 2015 | Reduce 14% | 63,505,000 | 1.1% |
| Q3 2015 | Reduce 33% | 74,205,000 | 1.3% |
| Q2 2015 | Add 1% | 110,330,000 | 1.7% |
| Q1 2015 | Reduce 13% | 109,752,000 | 1.4% |
| Q4 2014 | Add 10% | 125,936,000 | 1.5% |
| Q3 2014 | No change | 113,979,000 | 2.1% |
| Q2 2014 | Add 206% | 114,059,000 | 2.2% |
| Q1 2014 | Reduce 6% | 37,254,000 | 0.7% |
| Q4 2013 | Reduce 48% | 39,568,000 | 0.8% |
| Q3 2013 | Reduce 8% | 75,868,000 | 1.5% |
| Q2 2013 | Reduce 6% | 82,158,000 | 1.7% |
| Q1 2013 | Reduce 15% | 87,254,000 | 2.0% |
| Q4 2012 | Add 12% | 103,254,000 | 2.0% |
| Q3 2012 | Add 6% | 92,104,000 | 1.7% |
| Q2 2012 | Add 21% | 86,819,000 | 1.5% |
| Q1 2012 | First 13F | 71,775,000 | 1.3% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.